{"id":"https://openalex.org/W87228708","doi":null,"title":"[Anti-angiogenesis effect of metronomic chemotherapy in multiple myeloma patients].","display_name":"[Anti-angiogenesis effect of metronomic chemotherapy in multiple myeloma patients].","alternate_titles":[],"publication_year":2012,"publication_date":"2012-06-01","ids":{"openalex":"https://openalex.org/W87228708","mag":"87228708","pmid":"https://pubmed.ncbi.nlm.nih.gov/22967380"},"language":"zh","primary_location":{"id":"pmid:22967380","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22967380","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi","raw_type":"Clinical Trial"},"parent_works":[],"lineage":["https://openalex.org/W87228708"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100550952","display_name":"Lieping Guo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lie-ping Guo","raw_affiliation_strings":["Shanghai Zhabei District Central Hospital, Shanghai 200070, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shanghai Zhabei District Central Hospital, Shanghai 200070, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100730438","display_name":"Fan Zhou","orcid":"https://orcid.org/0000-0002-2024-7698","observed_orcids":["https://orcid.org/0000-0002-2024-7698"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fan Zhou","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100323687","display_name":"Wei Wei","orcid":"https://orcid.org/0000-0002-1465-0069","observed_orcids":["https://orcid.org/0000-0002-1465-0069"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wei Wei","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062569053","display_name":"Yi-zi Zhang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yi-zi Zhang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006509425","display_name":"Haotian Shi","orcid":"https://orcid.org/0000-0003-0328-0071","observed_orcids":["https://orcid.org/0000-0003-0328-0071"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hao-tian Shi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103793762","display_name":"Chen-hui Lin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chen-hui Lin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100386314","display_name":"Lu Li","orcid":"https://orcid.org/0000-0002-1920-4965","observed_orcids":["https://orcid.org/0000-0002-1920-4965"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lu Li","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5004786474","display_name":"Jian Hou","orcid":"https://orcid.org/0009-0008-9343-5332","observed_orcids":["https://orcid.org/0009-0008-9343-5332"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jian Hou","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.00910986,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"33","issue":"6","first_page":"457","last_page":"460"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9309999942779541},{"id":"https://openalex.org/keywords/metronomic-chemotherapy","display_name":"metronomic chemotherapy","score":0.9900000095367432},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.8970000147819519},{"id":"https://openalex.org/keywords/prednisone","display_name":"prednisone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/angiogenesis-inhibition","display_name":"angiogenesis inhibition","score":0.9120000004768372},{"id":"https://openalex.org/keywords/microvessel-density","display_name":"microvessel density","score":0.8500000238418579},{"id":"https://openalex.org/keywords/bone-marrow","display_name":"bone marrow","score":0.8640000224113464},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.996999979019165},{"id":"https://openalex.org/keywords/pdgf-bb","display_name":"PDGF-BB","score":0.9599999785423279},{"id":"https://openalex.org/keywords/relapsed-refractory-multiple-myeloma","display_name":"relapsed/refractory multiple myeloma","score":0.7820000052452087},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.6129999756813049},{"id":"https://openalex.org/keywords/oral-chemotherapy","display_name":"oral chemotherapy","score":0.5040000081062317},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.3019999861717224},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.41499999165534973},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.6169999837875366}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7664279937744141},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6698929071426392},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.6526017189025879},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.6425010561943054},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.5740564465522766},{"id":"https://openalex.org/C2777025900","wikidata":"https://www.wikidata.org/wiki/Q29725","display_name":"Vascular endothelial growth factor","level":3,"score":0.5674907565116882},{"id":"https://openalex.org/C2778720950","wikidata":"https://www.wikidata.org/wiki/Q424972","display_name":"Prednisone","level":2,"score":0.5646956562995911},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5420591831207275},{"id":"https://openalex.org/C2776436680","wikidata":"https://www.wikidata.org/wiki/Q1632335","display_name":"Microvessel","level":3,"score":0.5357334613800049},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.5196517705917358},{"id":"https://openalex.org/C2775960820","wikidata":"https://www.wikidata.org/wiki/Q408378","display_name":"Growth factor","level":3,"score":0.4284956455230713},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4258318543434143},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.1875133514404297},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077214","descriptor_name":"Becaplermin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000098","qualifier_name":"blood supply","is_major_topic":true},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011241","descriptor_name":"Prednisone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D020574","descriptor_name":"Proto-Oncogene Proteins c-sis","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D055806","descriptor_name":"Microvessels","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:22967380","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22967380","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi","raw_type":"Clinical Trial"},{"id":"mag:87228708","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22967380","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2328514805","https://openalex.org/W2039853752","https://openalex.org/W2369162713","https://openalex.org/W137145377","https://openalex.org/W959180624","https://openalex.org/W2184469763","https://openalex.org/W1972331058","https://openalex.org/W2163893654","https://openalex.org/W2370422115","https://openalex.org/W2981909675"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"investigate":[2],"effects":[3],"of":[4,15,49,65,91,114,145,164,183,208,253,258,279,318,328],"low-dose":[5,310],"cyclophosphamide":[6,51],"and":[7,24,55,62,71,121,175,194,212,255,268,282,331],"prednisone":[8,56],"(CP)":[9],"metronomic":[10,46,141,202,244,312],"chemotherapy":[11,47,245,313],"on":[12],"microvessel":[13,143,209,249,316],"density":[14,113,317],"bone":[16,115,146,319],"marrow,":[17],"serum":[18,106,122,329],"vascular":[19],"endothelial":[20],"growth":[21,27],"factor":[22,28],"(VEGF)":[23],"platelet":[25],"derived":[26],"BB":[29],"(PDGF-BB)in":[30],"multiple":[31],"myeloma":[32],"(MM)":[33],"patients.":[34,133,323],"METHODS:":[35],"54":[36],"refractory":[37],"or":[38,102,108],"relapsed":[39],"MM":[40,322],"patients":[41],"were":[42,68,85,96,151,166,185,205,260,275],"treated":[43,241],"with":[44,87,286],"CP":[45,140,201,243,311],"consisted":[48],"oral":[50],"(CTX,":[52],"50":[53],"mg/d)":[54],"(Pred,":[57],"15":[58],"mg/d).":[59],"Bone":[60],"marrow":[61,116,147,320],"peripheral":[63],"blood":[64],"each":[66],"patient":[67],"collected":[69],"before":[70],"2,":[72,135],"4,":[73,136],"6":[74,100,137],"months":[75,101,138],"after":[76,240],"treatment.":[77],"Among":[78],"the":[79,88,130,149,162,181,231,238,251,256],"37":[80,131],"assessable":[81,132],"patients,":[82],"30":[83],"cases":[84,95],"responsive":[86],"response":[89],"rate":[90],"81.08%.":[92],"Another":[93],"17":[94],"follow-uped":[97],"less":[98],"than":[99,215],"failure":[103],"to":[104,110,333],"obtain":[105],"samples":[107],"lost":[109],"follow-up.":[111],"Microvessel":[112],"was":[117,125],"measured":[118],"by":[119,127,242],"immunohistochemistry":[120],"VEGF/PDGF-BB":[123],"expression":[124,252,257,327],"analyzed":[126],"ELISA":[128],"in":[129,148,237,321,337],"RESULTS:":[134],"following":[139],"chemotherapy,":[142,203],"densities":[144],"responders":[150,232],"33.1":[152],"\u00b1":[153,156,159,168,172,177,187,191,196,219,223,228,262,265,270,290,293,298],"4.8/HP,":[154],"24.8":[155],"3.7/HP,":[157],"19.7":[158],"2.1/HP":[160],"respectively;":[161,180],"expressions":[163,182],"VEGF":[165,211,221,254,281,330],"(394":[167],"57)":[169],"ng/L,":[170,189,225,295],"(268":[171],"32)":[173],"ng/L":[174,179,193,198,267,272],"(217":[176],"20)":[178],"PDGF-BB":[184,213,226,259,283,296,332],"(304":[186],"31)":[188,192],"(274":[190],"(196":[195],"22)":[197],"respectively.":[199,273],"After":[200],"there":[204],"significantly":[206],"lower":[207],"density,":[210,250],"levels":[214,284],"pretreatment":[216,287],"\\[MVD":[217,288],"48.5":[218],"5.9/HP,":[220],"(517":[222],"60)":[224,229],"(484":[227],"ng/L\\]in":[230],"(P":[233,301],"<":[234],"0.01).":[235],"While":[236],"non-responders,":[239],"for":[246],"2":[247],"months,":[248],"32.5":[261],"4.7/HP,":[263],"512":[264],"39":[266],"(452":[269],"39)":[271],"There":[274],"no":[276],"significant":[277],"changes":[278],"MVD,":[280],"compared":[285],"33.2":[289],"5.6/HP,VEGF":[291],"(498":[292],"55)":[294],"(488":[297],"44)":[299],"ng/L\\]":[300],">":[302],"0.05).":[303],"CONCLUSIONS:":[304],"Our":[305],"findings":[306],"suggested":[307],"that":[308],"continuous":[309],"could":[314],"decrease":[315],"Furthermore,":[324],"it":[325],"down-regulated":[326],"exert":[334],"its":[335],"anti-angiogenesis":[336],"MM.":[338]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W87228708","counts_by_year":[{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-15T12:55:33.944570","created_date":"2016-06-24T00:00:00"}
